OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
FULNYSE67

FULLER H B CO

Specialty ChemicalsVerified

Capital Structure and Liquidity H.B. Fuller maintains a debt-to-equity ratio of 1.01, indicating a balanced capital structure with total liabilities of $3.15 billion and equity of $2.07 billion. The company's liquidity position is characterized by a current ratio of 1.92, supported by $107.88 million in cash and equivalents. However, the company reported negative operating cash flow of $3.97 million and free cash flow of -$61.68 million in Q1 2026, raising concerns about short-term liquidity. ### Profitability and Returns The company's return on equity (ROE) of 1.02% and return on assets (ROA) of 0.4% fall below typical thresholds for healthy performance in the specialty chemicals industry. With a net income of $21.05 million on gross profit of $236.05 million, the company's profitability appears constrained by high operating costs and capital expenditures. ### Segments and Geographic Exposure H.B. Fuller operates through three primary segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives. The company's product portfolio spans industrial adhesives, construction sealants, and consumer-focused adhesive solutions. While the input data does not specify geographic revenue concentration, the company's operations suggest exposure to both domestic and international markets. ### Growth Trajectory The company's growth trajectory is influenced by its capital expenditures of $57.70 million in Q1 2026, reflecting ongoing investments in production capabilities. The outlook for the current fiscal year indicates potential challenges, given the negative free cash flow and the need for continued capital investment. ### Risk Factors The company faces medium liquidity risk due to negative free cash flow and a debt-to-equity ratio near 1.0. Dilution risk is also rated as medium, with source documents mentioning potential dilution or offering risk. The company's reliance on petroleum-based raw materials exposes it to supply chain volatility and price fluctuations. ### Recent Events Recent filings highlight the company's efforts to maintain sufficient borrowing capacity through its revolving credit facility with a maturity extending beyond twelve months. The company is also evaluating the impact of new guidance requiring additional disclosures about federal, state, and foreign income taxes.

30-day price · FUL(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyFULLER H B CO
ExchangeNYSE
TickerFUL
CIK0000039368
SICAdhesives & Sealants
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. H.B. Fuller Company is a pureplay adhesives company that formulates, manufactures, and markets adhesives, sealants, and specialty chemical products for industrial, construction, and consumer markets.

Classification. The company is classified in the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with 0.92 confidence based on verified market data.

### Capital Structure and Liquidity H.B. Fuller maintains a debt-to-equity ratio of 1.01, indicating a balanced capital structure with total liabilities of $3.15 billion and equity of $2.07 billion. The company's liquidity position is characterized by a current ratio of 1.92, supported by $107.88 million in cash and equivalents. However, the company reported negative operating cash flow of $3.97 million and free cash flow of -$61.68 million in Q1 2026, raising concerns about short-term liquidity. ### Profitability and Returns The company's return on equity (ROE) of 1.02% and return on assets (ROA) of 0.4% fall below typical thresholds for healthy performance in the specialty chemicals industry. With a net income of $21.05 million on gross profit of $236.05 million, the company's profitability appears constrained by high operating costs and capital expenditures. ### Segments and Geographic Exposure H.B. Fuller operates through three primary segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives. The company's product portfolio spans industrial adhesives, construction sealants, and consumer-focused adhesive solutions. While the input data does not specify geographic revenue concentration, the company's operations suggest exposure to both domestic and international markets. ### Growth Trajectory The company's growth trajectory is influenced by its capital expenditures of $57.70 million in Q1 2026, reflecting ongoing investments in production capabilities. The outlook for the current fiscal year indicates potential challenges, given the negative free cash flow and the need for continued capital investment. ### Risk Factors The company faces medium liquidity risk due to negative free cash flow and a debt-to-equity ratio near 1.0. Dilution risk is also rated as medium, with source documents mentioning potential dilution or offering risk. The company's reliance on petroleum-based raw materials exposes it to supply chain volatility and price fluctuations. ### Recent Events Recent filings highlight the company's efforts to maintain sufficient borrowing capacity through its revolving credit facility with a maturity extending beyond twelve months. The company is also evaluating the impact of new guidance requiring additional disclosures about federal, state, and foreign income taxes.
Key takeaways
  • H.B. Fuller maintains a balanced capital structure with a debt-to-equity ratio of 1.01.
  • The company's ROE of 1.02% and ROA of 0.4% indicate weak profitability relative to industry standards.
  • Negative free cash flow of -$61.68 million in Q1 2026 raises liquidity concerns.
  • The company's reliance on petroleum-based raw materials exposes it to supply chain volatility.
  • The company is evaluating new tax disclosure requirements that may impact financial statement disclosures.
  • ## RATIONALES
  • ```json
  • {
Financial snapshot
PeriodQ1 2026
CurrencyUSD
Revenue
Gross profit$236.0M
Operating income
Net income$21.0M
R&D
SG&A
D&A$46.4M
SBC$5.3M
Operating cash flow-$4.0M
CapEx$57.7M
Free cash flow-$61.7M
Total assets$5.22B
Total liabilities$3.15B
Total equity$2.07B
Cash & equivalents$107.9M
Long-term debt$2.08B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY2025$152.0M$121.2M
FY2025
FY2024$348.2M$130.3M$163.2M
FY2025$130.3M$163.2M
FY2025$130.3M
PeriodGross %Op %Net %FCF %
FY2025
FY2025
FY2024
FY2025
FY2025
PeriodAssetsEquityCashDebt
FY2025$5.18B$2.00B$107.2M
FY2025
FY2024$4.93B$1.83B$169.4M
FY2025$4.93B$1.83B$169.4M
FY2025
PeriodOCFCapExFCFSBC
FY2025$263.5M$142.3M$121.2M$22.1M
FY2025
FY2024$302.4M$139.2M$163.2M$21.9M
FY2025$302.4M$139.2M$163.2M$21.9M
FY2025
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
Q1 2026$21.0M-$61.7M
Q1 2026
Q3 2025$256.6M$122.2M$62.2M
Q2 2025$146.5M$55.1M-$6.8M
PeriodGross %Op %Net %FCF %
Q1 2026
Q1 2026
Q3 2025
Q2 2025
PeriodAssetsEquityCashDebt
Q1 2026$5.22B$2.07B$107.9M
Q1 2026$5.18B$2.00B$107.2M
Q3 2025$5.17B$1.96B$122.5M
Q2 2025$5.13B$1.87B$96.8M
PeriodOCFCapExFCFSBC
Q1 2026-$4.0M$57.7M-$61.7M$5.3M
Q1 2026
Q3 2025$156.8M$94.6M$62.2M$18.2M
Q2 2025$57.8M$64.5M-$6.8M$12.0M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book-$423.3M
Net cash-$1.97B
Current ratio1.9
Debt/Equity1.0
ROA0.4%
ROE1.0%
Cash conversion-19.0%
CapEx/Revenue
SBC/Revenue
Asset intensity0.2
Dilution ratio1.9%
Risk assessment
Dilution riskMedium
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
  • Source documents mention dilution or offering risk.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
MetricFULActivity
Op margin0.4% medp25 -8.0% · p75 16.0%
Net margin2.3% medp25 -11.6% · p75 11.8%
Gross margin20.8% medp25 14.9% · p75 24.0%
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue6.2% medp25 5.4% · p75 10.2%
Debt / equity101.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
market data ESG controversies score100.0
market data ESG governance pillar75.9
market data ESG social pillar32.4
market data insider trading score10.0
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
SEC filingstype companyfacts · CIK 0000039368 · 582 us-gaap concepts
2026-05-01 15:08 UTC#93ca4b5d
Source: analysis-pipeline (hybrid)Generated: 2026-05-01 15:10 UTCJob: d9553da7